Cover Story

Sickle cell disease poised for ‘golden age of treatment’ amid progress toward cure

HemOnc Today, June 10, 2019
As researchers work to expand curable approaches for sickle cell disease, new options for managing its acute and chronic complications appear within…
Feature

As Trump administration considers importing drugs from Canada, experts analyze risks, benefits

June 4, 2019
The idea of importing prescription drugs from Canada as a means to lower prices is back under scrutiny with President Donald J. Trump verbally…
Meeting News

CAR T-cell therapy total cost can exceed $1.5 million per treatment

May 29, 2019
PHILADELPHIA — When factoring in all the costs associated with chimeric antigen receptor T-cell therapy, hospitals may charge as much as $1.5…
Feature

Experts divided regarding impact from Trump’s plan to put drug prices in TV ads

May 29, 2019
HHS recently enacted one of the first concrete steps toward President Donald J. Trump’s pledge to lower drug prices in finalizing a federal…
Feature

‘Platelet decoys’ may lower blood clot risk, prevent cancer metastasis

May 28, 2019
A novel antiplatelet therapy showed potential in reducing blood clot risk and preventing cancer metastasis, according to preclinical research…
In the JournalsPerspective

New CAR T-cell Therapy Shows No Severe Toxic Side Effects

Cell Therapy Next, May 2019
A novel version of CAR T-cell therapy has shown no severe toxic side effects in patients with recurrent lymphoma, according to a study published in…
Cover Story

‘A Moment of Marvel’ in Manhattan Brings a Revolution in CAR T-Cell Therapy

Cell Therapy Next, May 2019
When the first flow cytometry analysis was run after a CAR T-cell therapy, showing no evidence of leukemia, Michel Sadelain, MD, PhD, and Isabelle
Feature

Blood test may serve as noninvasive alternative to colonoscopy

May 24, 2019
A study underway in West Virginia is designed to evaluate a novel blood test that may prove a more acceptable alternative for patients unwilling to…
Feature

Single-dose pembrolizumab may induce remission in advanced melanoma

May 15, 2019
Patients with advanced melanoma appeared to experience durable remission with single-dose pembrolizumab initiated 3 weeks before surgery, according…
Feature

CAR T cells show potential for treatment of pediatric solid tumors

May 13, 2019
Researchers at Stanford University School of Medicine have used chimeric antigen receptor T cells targeting B7-H3 to attack certain solid tumors in…